Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPST-1495 in Endometrial or Colorectal Cancer Prior to Surgery
NCT06129604Phase 2Active, not recruiting
- Sponsor
- University of Oklahoma
- Start
- Apr 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tpst-1495 in endometrial carcinoma, colorectal carcinoma (CRC), sponsored by University of Oklahoma. Started Apr 2024; status: active, not recruiting.
02
Drugs
tpst-1495
03
Conditions
endometrial carcinomacolorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT06129604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06129604.